Cargando…
High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells
Skp2 is a crucial component of SCF(Skp2) E3 ubiquitin ligase and is often overexpressed in various types of cancer, including prostate cancer (PCa). The epithelial-to-mesenchymal transition (EMT) is involved in PCa progression. The acquisition of a mesenchymal phenotype that results in a cancer stem...
Autores principales: | Šimečková, Šárka, Kahounová, Zuzana, Fedr, Radek, Remšík, Ján, Slabáková, Eva, Suchánková, Tereza, Procházková, Jiřina, Bouchal, Jan, Kharaishvili, Gvantsa, Král, Milan, Beneš, Petr, Souček, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451010/ https://www.ncbi.nlm.nih.gov/pubmed/30952903 http://dx.doi.org/10.1038/s41598-019-42131-y |
Ejemplares similares
-
The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells
por: Pernicová, Zuzana, et al.
Publicado: (2014) -
Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells
por: Slabáková, Eva, et al.
Publicado: (2015) -
Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs
por: Slabáková, Eva, et al.
Publicado: (2021) -
Variability of fluorescence intensity distribution measured by flow cytometry is influenced by cell size and cell cycle progression
por: Fedr, Radek, et al.
Publicado: (2023) -
Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade
por: Mickova, Alena, et al.
Publicado: (2021)